Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of Vericheck ddPCRâ„¢ Empty-Full Capsid Kits for ...
Park Avenue Securities LLC increased its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 28.2% during the ...
Bio-Rad Laboratories (NYSE:BIO) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments ...
Gateway Investment Advisers LLC raised its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 47.5% during the ...
Bio-Rad Laboratories, Inc.’s BIO solid momentum in the QX600 Droplet Digital PCR (ddPCR) platform is poised to help it grow in the upcoming quarters. The clinical diagnostics business sees increased ...
Ariel Fund highlighted stocks like Bio-Rad Laboratories, Inc. (NYSE:BIO), in the third quarter 2024 investor letter. Bio-Rad ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of Vericheck ddPCRâ„¢ Empty-Full Capsid Kits for ...
RBC Capital analyst Conor McNamara maintained a Buy rating on Bio-Rad Laboratories (BIO – Research Report) today and set a price target of ...
Discover Nuvia wPrime 2A Media, the advanced mixed-mode resin by Bio-Rad for efficient biomolecule purification at small to ...